Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Shanghai Kaibao Pharmaceutical CO.,Ltd
—
Shanghai Kaibao Pharmaceutical CO.,Ltd is led by CEO Yingbin Zhou, employs 1,197 people, headquartered in Shanghai, CN, publicly traded since 2010.
Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) stock trades at $4.90 with a market capitalization of $5.26B. The stock is valued at a price-to-earnings (P/E) ratio of 20.12, price-to-book of 1.23, price-to-sales of 5.20. Over the past 52 weeks the stock has ranged between $4.02 and $6.77, and currently trades 27.6% below its 52-week high. It pays a dividend yielding 2.58%.
On profitability, Shanghai Kaibao Pharmaceutical CO.,Ltd generates a return on equity (ROE) of 6.04%, an operating margin of 19.62%, a net profit margin of 25.58%.
Official website: www.xykb.com
Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) — frequently asked questions
What is Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) stock price today?
Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) is currently trading at $4.90, down 0.81% today.
What is 300039.SZ P/E ratio?
Shanghai Kaibao Pharmaceutical CO.,Ltd's P/E ratio is 20.12. This is between 15x and 30x, around the typical market average of roughly 18-22x.
What is 300039.SZ return on equity (ROE)?
Shanghai Kaibao Pharmaceutical CO.,Ltd's return on equity (ROE) is 6.04%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Shanghai Kaibao Pharmaceutical CO.,Ltd's market cap?
Shanghai Kaibao Pharmaceutical CO.,Ltd has a market capitalization of $5.26B.
Does 300039.SZ pay a dividend?
Yes. Shanghai Kaibao Pharmaceutical CO.,Ltd currently yields 2.58%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 300039.SZ carry?
Shanghai Kaibao Pharmaceutical CO.,Ltd has a debt-to-equity ratio of 0.00. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300039.SZ's profit margin?
Shanghai Kaibao Pharmaceutical CO.,Ltd reports a net profit margin of 25.58% — the share of revenue left after every cost, including tax and interest.
What sector is 300039.SZ in?
Shanghai Kaibao Pharmaceutical CO.,Ltd is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300039.SZ listed on?
Shanghai Kaibao Pharmaceutical CO.,Ltd trades on SHZ under the ticker 300039.SZ.
What is 300039.SZ's 52-week range?
Over the last year Shanghai Kaibao Pharmaceutical CO.,Ltd has traded between $4.02 and $6.77.
Related — Stocks
Popular Stocks
Screens 300039.SZ currently matches
On the figures above, Shanghai Kaibao Pharmaceutical CO.,Ltd passes the filters for 19 of our ready-made screens, among them Dividend Stocks, Low Debt Dividend Stocks, Low Debt Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.